Correlation Between Neurobiological Technologies and Accustem Sciences

Can any of the company-specific risk be diversified away by investing in both Neurobiological Technologies and Accustem Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobiological Technologies and Accustem Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurobiological Technologies and Accustem Sciences, you can compare the effects of market volatilities on Neurobiological Technologies and Accustem Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobiological Technologies with a short position of Accustem Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobiological Technologies and Accustem Sciences.

Diversification Opportunities for Neurobiological Technologies and Accustem Sciences

0.0

Correlation Coefficient

Neurobiological Technologies  Accustem Sciences

Pay attention - limited upside

The 3 months correlation between Neurobiological and Accustem is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neurobiological Technologies and Accustem Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accustem Sciences and Neurobiological Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobiological Technologies are associated (or correlated) with Accustem Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accustem Sciences has no effect on the direction of Neurobiological Technologies i.e., Neurobiological Technologies and Accustem Sciences go up and down completely randomly.

Pair Corralation between Neurobiological Technologies and Accustem Sciences

If you would invest  28.00  in Accustem Sciences on September 24, 2024 and sell it today you would lose (4.00) from holding Accustem Sciences or give up 14.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.6%
Values	Daily Returns

Neurobiological Technologies  vs.  Accustem Sciences

Neurobiological Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurobiological Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, Neurobiological Technologies is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Accustem Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Accustem Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Neurobiological Technologies and Accustem Sciences

The main advantage of trading using opposite Neurobiological Technologies and Accustem Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobiological Technologies position performs unexpectedly, Accustem Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accustem Sciences will offset losses from the drop in Accustem Sciences' long position.

The idea behind Neurobiological Technologies and Accustem Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.